P. Koch

6.1k total citations · 1 hit paper
67 papers, 3.1k citations indexed

About

P. Koch is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, P. Koch has authored 67 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in P. Koch's work include Lymphoma Diagnosis and Treatment (29 papers), Lung Cancer Treatments and Mutations (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). P. Koch is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Lung Cancer Treatments and Mutations (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). P. Koch collaborates with scholars based in Germany, Switzerland and United States. P. Koch's co-authors include Volker Diehl, H. Löffler, Andreas Engert, Th. Büchner, E. Thiel, D. Hoelzer, Dirk Hasenclever, Emanuel Vogel, Johann Lex and Mathias Freund and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

P. Koch

67 papers receiving 3.0k citations

Hit Papers

Prognostic factors in a m... 1988 2026 2000 2013 1988 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P. Koch 1.5k 905 795 776 621 67 3.1k
Chul S. Ha 1.9k 1.3× 1.8k 2.0× 857 1.1× 693 0.9× 1.1k 1.7× 145 4.6k
Franca Fossati‐Bellani 1.2k 0.8× 1.2k 1.3× 712 0.9× 1.4k 1.8× 256 0.4× 83 4.3k
Robert B. Golbey 534 0.4× 1.7k 1.9× 380 0.5× 1.9k 2.4× 256 0.4× 79 4.8k
V. Bonfante 2.3k 1.6× 1.7k 1.9× 404 0.5× 941 1.2× 145 0.2× 61 3.5k
Josée M. Zijlstra 2.5k 1.7× 1.3k 1.5× 207 0.3× 1.2k 1.6× 317 0.5× 148 4.8k
Richard A. Gams 441 0.3× 968 1.1× 171 0.2× 393 0.5× 359 0.6× 64 2.1k
Laura Johnston 392 0.3× 907 1.0× 365 0.5× 268 0.3× 1.9k 3.1× 107 3.1k
Kuniaki Itoh 710 0.5× 866 1.0× 149 0.2× 193 0.2× 156 0.3× 125 1.9k
Jörg T. Hartmann 579 0.4× 3.4k 3.8× 176 0.2× 2.7k 3.5× 239 0.4× 69 5.8k
R. Erttmann 163 0.1× 858 0.9× 262 0.3× 563 0.7× 492 0.8× 83 2.6k

Countries citing papers authored by P. Koch

Since Specialization
Citations

This map shows the geographic impact of P. Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Koch more than expected).

Fields of papers citing papers by P. Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Koch. The network helps show where P. Koch may publish in the future.

Co-authorship network of co-authors of P. Koch

This figure shows the co-authorship network connecting the top 25 collaborators of P. Koch. A scholar is included among the top collaborators of P. Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Koch. P. Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koch, P., Stefan Herzig, & Jan Matthes. (2016). An expert protocol for immunofluorescent detection of calcium channels in tsA-201 cells. Journal of Pharmacological and Toxicological Methods. 82. 20–25. 2 indexed citations
2.
Engert, Andreas, Volker Diehl, Jeremy Franklin, et al.. (2009). Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study. Journal of Clinical Oncology. 27(27). 4548–4554. 303 indexed citations
3.
Koch, P., Hubert Desal, E. Auffray-Calvier, & A. De Kersaint-Gilly. (2005). Anévrysme mycotique cérébral : histoire naturelle et prise en charge thérapeutique. Journal of Neuroradiology. 32(4). 258–265. 11 indexed citations
5.
Lügering, Norbert, J. Menzel, Torsten Kucharzik, et al.. (2001). Impact of Miniprobes Compared to Conventional Endosonography in the Staging of Low-Grade Gastric MALT Lymphoma. Endoscopy. 33(10). 832–837. 17 indexed citations
6.
Pfreundschuh, Michael, Dirk Hasenclever, Markus Loeffler, et al.. (2001). Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF. Annals of Oncology. 12(4). 471–477. 10 indexed citations
7.
Rueffer, U., Kai Breuer, Andreas Josting, et al.. (2001). Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Annals of Oncology. 12(9). 1307–1311. 131 indexed citations
8.
Willich, Normann, Gabriele Reinartz, B. Reers, et al.. (2000). Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study. International Journal of Radiation Oncology*Biology*Physics. 46(4). 895–901. 42 indexed citations
9.
Reinartz, Gabriele, et al.. (1999). Analysis of Failures after Whole Abdominal Irradiation in Gastrointestinal Lympomas. Strahlentherapie und Onkologie. 175(12). 601–605. 9 indexed citations
11.
Diehl, Volker, M. Sieber, B. Lathan, et al.. (1997). BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease. Annals of Oncology. 8(2). 143–148. 104 indexed citations
12.
Verbeek, Walter, Bernhard Wörmann, P. Koch, et al.. (1997). S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes. Annals of Hematology. 74(5). 205–208. 16 indexed citations
13.
Koch, P., Søren Andersen, J. Blatter, et al.. (1995). Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer. Anti-Cancer Drugs. 6(Supplement 6). 49–54. 14 indexed citations
14.
Pfreundschuh, Michael, U. Rueffer, B. Lathan, et al.. (1994). Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.. Journal of Clinical Oncology. 12(3). 580–586. 95 indexed citations
15.
Paganelli, Giovanni, Patrizia Magnani, Felicia Zito, et al.. (1994). Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin. European Journal of Nuclear Medicine and Molecular Imaging. 21(4). 314–321. 46 indexed citations
16.
Haferlach, Torsten, W. Gaßmann, H. Löffler, et al.. (1993). Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. Annals of Hematology. 66(4). 165–170. 22 indexed citations
17.
Hiddemann, Wolfgang, et al.. (1991). Alpha interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone. European Journal of Cancer and Clinical Oncology. 27. S37–S39. 3 indexed citations
18.
Koch, P., et al.. (1990). An approach to differentiate between noradrenaline-elicited contractile processes in the rat isolated aorta. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(4). 454–61. 13 indexed citations
19.
Koch, P., et al.. (1989). Effect of Calmodulin Antagonists on Contraction and <sup>45</sup>Ca Movements in Rat Aorta. Pharmacology. 39(5). 317–326. 6 indexed citations
20.
Koch, P., et al.. (1988). Different effects of R 56865 and calcium entry blockers on K+- and noradrenaline-induced contractions and 45Ca uptake in rat aorta. European Journal of Pharmacology. 158(3). 183–190. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026